CHECKPOINT INHIBITOR
Clinical trials for CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a single drug free patients from insulin after immunotherapy?
Disease control Not yet recruitingThis pilot study tests whether infliximab can safely reverse insulin dependence in people who developed diabetes after checkpoint inhibitor cancer treatment. About 14 participants will receive the drug and be monitored for side effects and changes in their need for insulin. The g…
Matched conditions: CHECKPOINT INHIBITOR
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:40 UTC
-
Could a COVID shot boost liver cancer treatment?
Knowledge-focused Not yet recruitingThis study looks back at medical records of 200 liver cancer patients in Austria to see if getting an mRNA COVID-19 vaccine within three months before starting immunotherapy improves their response to cancer treatment. Researchers will also check if vaccination affects survival o…
Matched conditions: CHECKPOINT INHIBITOR
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC